Janus Global Life Sciences Fund (JAGLX)

Sector Experts Seeking Growth and Innovation in Health Care

SHARE CLASS

FUND FACTS (JAGLX)

Inception Date12/31/1998
NAV (As of 3/22/17)$49.83
Total Net Assets (As of 2/28/17)$3.41B
Annual Expense Ratio
(As of fiscal year end 9/30/16)
GROSS 0.94%
NET 0.94%

Morningstar Fee Level
(As of 2/28/17)
Fee Level Group
(out of 297 funds)
Specialty No Load

Performance (As of 12/31/16)
1 Year-12.39%
3 Year8.54%
5 Year19.94%
10 Year12.23%
Morningstar (As of 2/28/17)
CategoryUS Fund Health
Overall Rating™
(Based on risk-adjusted returns)

View All Ratings

125 Funds Rated
Equity
Style Box

Returns quoted are past performance and do not guarantee future results; current performance may be lower or higher. Investment returns and principal value will vary; there may be a gain or loss when shares are sold. For the most recent month-end performance click here.

Returns greater than one year are annualized.

PERFORMANCE View Time Period:
As of 3/22/17As of 2/28/17As of 12/31/16As of 12/31/16
Inception: Dec 31, 1998
PRICE1 DAY
RETURN

YTD
1 YR3 YR5 YR10 YRSINCE
INCEPTION
Class T Shares 
$49.830.30%10.41%16.04%7.40%20.08%12.98%11.24%-12.39%8.54%19.94%12.23%10.71%-12.39%27.87%148.25%217.12%523.97%
MSCI World Health Care Index8.34%
(03/21/2017)
-6.81%5.47%13.44%7.41%5.26%10.73%5.61%14.24%8.15%5.67%-6.81%17.31%87.89%104.30%151.80%
S&P 500® Index5.20%
(03/21/2017)
11.96%8.87%14.66%6.95%5.37%24.98%10.63%14.01%7.62%5.65%11.96%29.05%98.18%95.72%156.21%

Returns quoted are past performance and do not guarantee future results; current performance may be lower or higher. Investment returns and principal value will vary; there may be a gain or loss when shares are sold.

Annual Expense Ratio: Gross: 0.94% / Net: 0.94% View Fees and Expenses

RISK STATISTICS
VS. MSCI World Health Care Index
AS OF 2/28/17

VIEW RISK STATISTICS DEFINITIONS

Alpha
Compares the risk-adjusted performance of a portfolio to a benchmark index.
Beta
A measure of the volatility of a portfolio in comparison to a benchmark index.
R-Squared
Represents the percentage of the portfolio’s performance that can be explained by the general movements of a benchmark index.
Standard Deviation
Measures historical volatility.
Sharpe Ratio
Measures risk-adjusted performance by dividing the portfolio’s excess returns by the standard deviation of those returns.
Information Ratio
Measure of a portfolio management’s performance against risk and return relative to a benchmark or alternative measure.
FUNDINDEX
Alpha0.522.99N/AN/A
Beta1.331.191.001.00
R-Squared (%)82.5476.16100.00100.00
Standard Deviation17.9016.2212.4311.68
Sharpe Ratio0.411.230.471.14
Information Ratio0.210.71----

Statistics are for the Fund’s “parent” share class (typically that with the longest history).

MORNINGSTAR PERCENTILEView Time Period:
As of 12/31/16As of 2/28/17
1 YR3 YR5 YR10 YRSINCE
INCEPTION
Percentile Ranking (%)62471530246633142622
US Fund Health Category
Rank/Count
87 / 13962 / 13219 / 12735 / 11414 / 5691 / 13744 / 13118 / 12630 / 11313 / 56

CALENDAR YEAR PERFORMANCE

GROWTH OF A $10,000 HYPOTHETICAL INVESTMENT

UP AND DOWN MARKET CAPTURE

AS OF 2/28/173 YR UP MARKET CAPTURE3 YR DOWN MARKET CAPTURE5 YR UP MARKET CAPTURE5 YR DOWN MARKET CAPTURE
Janus Global Life Sciences Fund133.25%126.24%133.12%116.02%
MSCI World Health Care Index100.00%100.00%100.00%100.00%

Statistics are for the Fund’s “parent” share class (typically that with the longest history).

ANNUAL FEES & EXPENSES

AS OF FISCAL YEAR END 9/30/2016
CLASS T SHARES
Management Fees0.64%
12b-1 FeesN/A
Other Expenses0.30%
Total Gross Expenses0.94%
WaiversN/A
TOTAL NET EXPENSES0.94%